Compare IDEXX Laboratories, Inc. (IDXX) vs J B Hunt Transport Services Inc (JBHT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs J B Hunt Transport Services Inc — how do they compare? IDEXX Laboratories, Inc. trades at $519.87 (market cap $40.43B), while J B Hunt Transport Services Inc trades at $228.35 (market cap $21.45B). The key difference: IDEXX Laboratories, Inc. is the larger of the two by market cap, and J B Hunt Transport Services Inc pays a 0.79% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and J B Hunt Transport Services Inc for 45 Days on average.
| IDXX | JBHT | |
|---|---|---|
Market Cap | $40.43B | $21.45B |
Volume | 692,164 | 1,028,680 |
Sector | Health | Industrials |
52-Week High | $766.68 | $298.41 |
52-Week Low | $504.70 | $137.09 |
Typical Hold Time | 46 Days | 45 Days |
Enterprise Value | $41.32B | $22.59B |
Dividend Yield | — | 0.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $517.47, up 2.13% with strong earnings momentum after beating Q2 2026 estimates. The stock shows bearish technical signals but maintains robust fundamentals with 25.03% net margins and 74.21% ROE. Recent acquisitions like CoVetAI and expanded diagnostic platforms highlight growth initiatives, while analyst consensus remains bullish with a $665 price target representing 28.5% upside potential.
The outlook remains positive given consistent earnings beats and expanding veterinary diagnostics market share. Key risks include FX headwinds, weaker U.S. vet visits, and premium valuations at 36x P/E. Institutional ownership trends show mixed activity with recent insider selling, but long-term growth drivers in pet healthcare innovation support the bullish analyst stance.
JBHT trades at $228.91, up 2.82% today, with a bearish technical signal and neutral oscillators. The company reported revenue of $12.00B in 2025, with net income of $598.28M and a net margin of 5.31%. Recent earnings have consistently beaten estimates, but the stock faces headwinds from rising costs and multiple securities class action investigations announced in late September 2026.
The outlook is mixed: strong analyst consensus with a $289.40 price target suggests upside, but near-term risks from cost pressures and legal scrutiny cloud the picture. Earnings growth and freight demand remain key drivers, yet investor sentiment is cautious amid profit warnings and volatile diesel prices.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About J B Hunt Transport Services Inc
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).
Read more on JBHT →
